The hospital-acquired infections testing kits market consists of sales of hospital-acquired infections testing kits, devices, and related services by entities (organizations, sole traders, and partnerships). Hospital-acquired infections testing kits are used to check infections acquired from pathogens such as vancomycin-resistant enterococci (VRE), methicillin-resistant staphylococcus aureus (MRSA), multi-resistant gram-negative bacilli, norovirus, and clostridium difficile.
The global hospital acquired infections therapeutic market size is expected to reach USD 12.52 billion by 2028 according to a new study by Polaris Market Research. The report “Hospital Acquired Infections Therapeutic Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Antibacterial Drugs {Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, Others}, Antiviral Drugs, Antifungal Drugs); By Infection Type; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global hospital acquired infections testing kits market size is expected to grow from $1.12 billion in 2021 to $1.27 billion in 2022 at a compound annual growth rate (CAGR) of 12.7%.
The global hospital acquired infections testing kits market was worth $0.78 billion in 2018. It is expected to grow at a compound annual growth rate (CAGR) of 11.26% and reach $1.33 billion by 2023. Read more at http://bit.ly/35QRklo
Global Hospital Acquired Infections Testing Kits Market by The Business Research Company is segmented as Instrument And Reagents, Consumables https://bit.ly/36bi9Uf
This Report provided by GrandResearchStore is about, the Hospital Acquired Infections (HAI) basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on.
Avail more information from Sample Brochure of report @ https://goo.gl/XLgiPc A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Global Hospital Acquired Infections (HAI) Industry Market and future opportunities are provided in the report.
The major players in the hospital-acquired infections testing kits market are Becton, Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd., and Hologic.....@ @ https://bit.ly/3fBqXs8
Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
Get a sample brochure @ http://tinyurl.com/zmogup4 ‘Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016’, provides an overview of the Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for
Over an eight-year period of assessment 2018-2026, the global market for hospital-acquired pneumonia prevention is poised to witness moderate growth, according to a recent research report on the global hospital-acquired pneumonia prevention market. The report has been published by Persistence Market Research and is titled, “Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026.” The US$ 795 Mn market is likely to exhibit a CAGR of 4.7%, reaching a value in excess of US$ 1,100 Mn by the end of 2026.
According to a newly published report by Persistence Market Research titled “Hospital Acquired Infections (HAIs) Control Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” sales of hospital acquired infections control equipment is expected to be valued at US$ 5,450.6 Mn in 2018 and this is likely to increase to US$ 7,580.8 Mn in 2025, expanding at a CAGR of 4.8% during the study period.
Hospital-acquired Infection Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-acquired Infection Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The Hospital Infection Therapeutics Market Size is estimated to reach $14.9 billion by 2027 and is poised to grow at a CAGR of 4.5% over the forecast period of 2022-2027.
According to a newly published report by Persistence Market Research titled “Hospital Acquired Infections (HAIs) Control Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” sales of hospital acquired infections control equipment is expected to be valued at US$ 5,450.6 Mn in 2018 and this is likely to increase to US$ 7,580.8 Mn in 2025, expanding at a CAGR of 4.8% during the study period.
The development of technologically advanced products is positively impacting the hospital-acquired infection (HAI) diagnostics domain. Advancements in technology have revolutionized the HAI diagnostics domain by enabling the development of products that offer reliable results in less time. For instance, in 2017, Roche Diagnostics launched the cobas Liat PCR system with four assays with the ability to conduct a real-time PCR nucleic acid test for Clostridium difficile detection in 20 minutes.
According to a newly published report by Persistence Market Research titled “Hospital Acquired Infections (HAIs) Control Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” sales of hospital acquired infections control equipment is expected to be valued at US$ 5,450.6 Mn in 2018 and this is likely to increase to US$ 7,580.8 Mn in 2025, expanding at a CAGR of 4.8% during the study period.
Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being multidrug resistant, these organisms are immune to the conventional antibiotics hence difficult to treat.
Pharmaion Consultants offers latest market research report “United States Hospital-acquired Infections Prevention Market Opportunities, 2010 - 2020” that studies the market size and share of various segments and sub-segments of the hospital-acquired infections prevention market in the United States during the period 2010 - 2020.
According to the latest research report by IMARC Group, The global hospital gowns market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.86% during 2024-2032. More Info:- https://www.imarcgroup.com/hospital-gowns-market
The Global Hospital Gowns Market is estimated to witness growth at a CAGR of 11.83% during the forecast period of 2023 to 2030. Request a Free Sample Report
According to the latest research report by IMARC Group, The global hospital gowns market size reached US$ 4.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.4% during 2023-2028. More Info:- https://www.imarcgroup.com/hospital-gowns-market
World over, the growing incidence of chronic diseases coupled with an increase in hospital-acquired infections (HAIs) are poised to expand the dynamics of the hospital disinfectant products market. Evidently, the COVID-19 outbreak significantly spiraled the demand for surgical disinfectants in clinics, hospitals, and other medical institutions.
The Incontinence Products Market is estimated to grow from USD 22.4 billion in 2020 to USD 35.4 billion by 2026 at a healthy CAGR of 8.1% during the forecast period.
The hospital gowns market is expected to reach US$ 4,542.67 million by 2027 from US$ 2,620.88 million in 2019. The market is estimated to grow at a CAGR of 7.2% from 2020 to 2027.
DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology. For more information on ABSSSI market, click here: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast
DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology. For more information on ABSSSI market, click here: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast
The Global HIV Diagnosis Market is projected to grow from USD 3.12 billion in 2020 to USD 5.28 billion by 2026 at a CAGR of over 9.2% during the forecast period.
ABSSSI is defined as a bacterial infection of Skin with a lesion size area of ≥75 cm2. ABSSSIs consist of the most frequently diagnosed skin infections worldwide.
Hospital Infection Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Infection Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource.
Get a sample brochure @ http://tinyurl.com/zh7xxa7 Medical nonwoven disposables are indispensable products in the field of healthcare. These products are surpassing woven fabrics in terms of popularity as they offer better hygiene conditions and effectively aid in avoiding contamination and infections. Rise in the incidences of Hospital-acquired infections and incontinence problems in adults globally are creating a need for medical nonwoven disposables in the market. The rising popularity of the medical nonwoven disposables among doctors and a global rise in health awareness are largely driving the market growth. Further, rising per capita healthcare spending, stringent government regulations regarding health and hygiene, especially in hospital setup, a global increase in aging population and improving lifestyle boost the growth of global medical nonwoven disposables market.
Get a sample brochure @ http://tinyurl.com/hf932af The market for Medical nonwoven disposables in the Asia Pacific region is set to witness a remarkable growth during the forecast period, mainly due to the increasing demand for advanced healthcare facilities, increasing count of aging population, growing awareness for the prevention of hospital acquired infections and its advantages over woven products.
An outlook on Hospital gowns market growth is presented in this latest research report that reviews industry growth drivers, trends, regional factors & companies as well as provides forecasts for next few years.
The global hospital supplies market accounted to US$ 37.9 Bn in 2018 and is expected to grow at a CAGR of 11.9% during the forecast period 2019 – 2027, to account to US$ 101.0 Bn by 2027. Get sample PDF copy: https://www.theinsightpartners.com/sample/TIPRE00003520/
The Acquired immunodeficiency syndrome (AIDS) testing and treatment market is expected to grow at a CAGR of 4.7% from 2021 to 2028. Acquired immunodeficiency syndrome (AIDS) is the most catastrophic, widespread and incurable disease prevalent across the world. In a report published in 2013 by the World Health Organization (WHO), total death accounted at rank six when compared on the parameter of total deaths by a disease and and approximated 35 million people across the globe are affected by it.
Hospital capacity management includes software and services provided by players that empower hospital executives, administrators and clinical staff with real-time hospital capacity planning and asset tracking.
Rodenticides Market has a significant scope for growth and is projected to grow at a CAGR of 5.0% from 2020, to reach a value of USD 6.6 billion by 2026. Impact of Covid-19 on Rodenticides Market
According to a revised report published by Persistence Market Research, the global disinfection robots market valued at US$ 1 Bn in 2020, and is predicted to surge at a CAGR of more than 15% during the forecast period (2021–2031).
Chlorhexidine Gluconate Solution Market size is forecast to reach $196.1 million by 2026, after growing at a CAGR of 3.2% during 2021-2026. Chlorhexidine Gluconate is a gluconate salt form of the chlorhexidine. It is a biguanide compound that is used in the antiseptic agent for tropical antibacterial activity.
The market for hospital supplies is continuously growing due to high incidence rate of inflammatory and communal diseases such as pneumococcal disease and sexually transmitted diseases.
The Hospital Disinfectant Products & Services Market is expected to grow at a healthy CAGR during the forecast period. This can be attributed to increasing automation in various applications across all end-use industries.
JSB Market Research published latest report titled "Global and USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)" Browse complete report @ http://goo.gl/CYCwde
The global sterilization equipment market is estimated to be over US$ 7.0 Bn in 2017. It is anticipated to grow at a double-digit CAGR from 2019 to 2030.
Point of care molecular diagnostics market is expected to reach a market value of USD 5.12 billion by 2027 growing at a CAGR of 12.9% in the forecast period of 2020-2027. The growing awareness regarding the testing methods among patients has been directly impacting the growth of point of care molecular diagnostics market.
Accelerating elderly population base prone to pressure injuries or bedsores will further augment demand for such devices. As per UN 2012 estimates, worldwide geriatric population will double by 2050 to reach an estimated value of more than 2.0 billion boosting market growth in the future. Moreover, major causes of pressure ulcers include lack of mobility, dry or moist skin, spinal injuries, osteoarthritis, poor circulation due to heavy smoking habits, shearing and friction which removes top layers of skin leading to pain and infection to patients who are admitted in the hospitals for long duration and are bedridden.
Antimicrobial Coatings Market size generated over USD 2.4 billion revenue in 2015 and industry expects gains at over 10% CAGR up to 2024. Strong application outlook in medical device industry should favor antimicrobial coatings market size. Key industry participants include in Antimicrobial Coatings Market are AzkoNobel, DuPont, BASF, Dow Microbial Control and DSM, Diamond Vogel Paints, Nippon Paint, RPM, Sherwin-Williams, Troy Corporation, AK, Arch Lonza and Sono-Tek Corporation.